Recipharm AB - Company Profile
Powered by 
All the sales intelligence you need on Recipharm AB in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Recipharm AB fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Recipharm AB.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Recipharm AB (Recipharm) is a pharmaceutical Contract Development and Manufacturing Organisation (CDMO). It provides end-to-end services for the entire product lifecycle, from drug substance development to commercial manufacturing. The company specializes in both small molecules and biologics, offering services in various modalities, including RNA therapies, biologics manufacturing and gene therapy. Recipharm also provides solutions for solid dosage forms, aseptic fill and finish, and specialized products such as ophthalmics and vaccines. The company operates a global network of facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK, and the US. Recipharm is headquartered in Stockholm, Sweden.
Headquarters
Sweden
Address
Box 603, Drottninggatan 29, Stockholm, SE-10132
Website
www.recipharm.com
Telephone
46 8 6025200
No of Employees
4,943
Industry
Pharmaceuticals and Healthcare
Revenue (2024)
$894.7M
Recipharm AB premium industry data and analytics
Products and Services
| Services |
|---|
| ATMP Fill and Finish |
| Biologics Development |
| Biologics Manufacturing |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In January, the company entered into a strategic partnership with Spektus Pharma to develop and supply a portfolio of novel Central Nervous System (CNS) focused products. |
| 2024 | Contracts/Agreements | In October, the company collaborated with LenioBio to scale up protein manufacturing capabilities and expedite vaccine production. |
| 2024 | Contracts/Agreements | In October, the company entered an exclusive strategic alliance with Exela aimed at enhancing sterile manufacturing capabilities in the US. |
Competitor Comparison
| Key Parameters | Recipharm AB | Vetter Pharma-Fertigung GmbH & Co KG | Corden Pharma International GmbH | Lichtenheldt GmbH | Iconovo AB |
|---|---|---|---|---|---|
| Headquarters | Sweden | Germany | Germany | Germany | Sweden |
| City | Stockholm | Ravensburg | Plankstadt | Wahlstedt | Lund |
| State/Province | Stockholm | Baden-Wurttemberg | - | Schleswig-Holstein | Vastra Gotaland |
| No. of Employees | 4,943 | 6,590 | 3,000 | 227 | 13 |
| Entity Type | Private | Private | Private | Private | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Richard Ridinger | Chairman | Executive Board | 2021 | 65 |
| Greg Behar | Chief Executive Officer | Senior Management | 2024 | - |
| Rodolfo J. Savitzky | Chief Financial Officer | Senior Management | 2025 | - |
| Luc Burgard | Chief Operating Officer | Senior Management | 2022 | - |
| Neil Jones | Chief Commercial Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer